Why the study?
Does low-dose aspirin increase the frequency of gastroduodenal mucosal defects in patients with ischemic heart disease?
Population
236 patients with ischemic heart disease
Comparison
Low-dose aspirin vs No aspirin use
Design
Cross-sectional
Authors
Loading...
Low-dose aspirin was associated with more gastroduodenal mucosal defects in IHD; hypothesis-generating for gastroprotection trials.
Does low-dose aspirin increase the frequency of gastroduodenal mucosal defects in patients with ischemic heart disease?
Low-dose aspirin use in patients with ischemic heart disease is associated with a significantly increased frequency of gastroduodenal mucosal defects compared to nonusers.
Nema et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: